Quantcast

Daily Archives: December 10, 2006

Barron’s Digest December 11,2006 Issue

Posted: December 10, 2006 at 8:27 pm

Stocks: (MEL)(STN)(ASCA)(PNK)(PENN)(ISLE)(INTU)(MDT)(NT)(GHS)(TRB)(GCI)(LEE)(JRC)(ACL)(VOD)(PFE)(EDS)(DIS)(AAPL)Mellon and Bank of New York have announced a merger and Barron's had suggested that there needed to be an event to unlock Mellon value. The bank's shares, currently ...
Read Full Story »

No Catching Google For Microsoft Online

Posted: December 10, 2006 at 5:58 pm

Microsoft's MSN and other online businesses used to be a pretty big deal. They sat at the top of the pack with AOL and Yahoo!. That was before social networking ...
Read Full Story »

More Oil Gets Freed Up

Posted: December 10, 2006 at 3:41 pm

Congress has finally passed a bill that will allow oil companies to drill for the 1.26 billion barrels of oil that sit below the Gulf of Mexico south of the ...
Read Full Story »

Is Telecom TV Bad For Cable’s Business?

Posted: December 10, 2006 at 3:34 pm

Stocks:  (TWX)(VZ)(CMCSA)(CVC)(T)I would appear that when two companies offer TV and other services over lines into the home, prices drop a lot. According to the American Consumer Institute, the drop ...
Read Full Story »

Citi’s M&A Addiction

Posted: December 10, 2006 at 3:20 pm

Stocks: (C)(JPM)(BAC)(PUK)There is no amount of bad press or investor discontent that can keep Citigroup from buying new pieces to add to its empire. Now that the rumors of a ...
Read Full Story »

GlaxoSmithKline May Benefit from Weak U.S. Dollar

Posted: December 10, 2006 at 11:32 am

GlaxoSmithKline (GSK) is a pharmaceutical stock which has outperformed the S&P with less volatility, and which may also benefit if the U.S. Dollar continues to weaken against European currencies. And ...
Read Full Story »

Biotech & Medical Venture Deals Roundup

Posted: December 10, 2006 at 11:30 am

From BioHealth Investorby Adam RubensteinNeoVista, Inc. (Fremont, CA), an ophthalmic device company focused on the treatment of age-related macular degeneration, has raised $41M in Series C funding. Essex Woodlands Health ...
Read Full Story »